Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-23-000101
Filing Date
2023-12-13
Accepted
2023-12-13 16:49:19
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1702504149.html 4  
1 FORM 4 wk-form4_1702504149.xml 4 5362
  Complete submission text file 0001599298-23-000101.txt   6954
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Dhingra Ankur (Reporting) CIK: 0001849682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 231484596